AI-enabled stethoscope doubles detection of valvular heart disease

A new study published today, Thursday, February 5, 2026, in the European Heart Journal – Digital Health, reveals a significant advancement in the detection of valvular heart disease. Researchers have found that an AI-enabled digital stethoscope more than doubles the identification of moderate to severe cases during routine clinical examinations compared to traditional stethoscopes.

Improved Detection Rates

The US-based study assessed 357 patients aged 50 and above with risk factors for heart disease. Participants, with a median age of 70 and 61.9% women, were evaluated using both standard and AI-enhanced stethoscopes. The AI-stethoscope demonstrated 92.3% sensitivity in detecting heart sound patterns indicative of valvular heart disease, a substantial increase from the 46.2% sensitivity achieved with traditional methods.

Did You Know? Valvular heart disease can affect more than one in two adults over 65 years old.

The Significance of Early Diagnosis

Valvular heart disease often goes undetected, even though it can lead to serious complications like arrhythmia, heart failure, increased hospitalizations, and even be fatal. Symptoms can be vague or absent, meaning many patients are unaware of their condition until it progresses. Dr. Rosalie McDonough, Senior Author of the study, emphasized that earlier diagnosis could prevent complications and worsening health.

How the Technology Works

The AI-enabled digital stethoscope records high-fidelity heart sounds and uses machine-learning algorithms to identify patterns associated with valvular heart disease. Unlike traditional stethoscopes, which rely on a clinician’s hearing and experience and can be affected by external factors, the AI provides an additional analytical layer. Patients flagged as at-risk will be referred for echocardiography to confirm the diagnosis.

Expert Insight: This technology doesn’t replace the expertise of healthcare professionals, but rather provides them with a tool to increase their confidence in patient assessments.

Researchers also observed that patients seemed more engaged during appointments when the AI-enabled stethoscope was used, potentially due to their ability to see and hear the data being analyzed. While the AI stethoscope showed a minor reduction in specificity, potentially leading to more false positives, the study authors believe the benefits of earlier detection outweigh this risk.

What’s Next?

Further research is needed to evaluate the AI-enabled stethoscope’s performance in diverse clinical settings and with broader patient populations. Wider adoption of this technology could lead to reduced hospital admissions and lower overall healthcare costs. Analysts expect that continued development of AI-powered diagnostic tools will play an increasingly important role in preventative healthcare.

Frequently Asked Questions

What is valvular heart disease?

Valvular heart disease can affect heart function, reducing a person’s capacity to carry out physical activities, and is associated with arrhythmia, heart failure, increased hospitalisation and can be fatal.

How does the AI-enabled stethoscope improve detection?

The AI-enabled digital stethoscope demonstrated significantly higher sensitivity – 92.3% – in detecting the heart sound patterns that indicate valvular heart disease compared to 46.2% with a traditional stethoscope.

What happens after a patient is flagged by the AI stethoscope?

Patients that are flagged as being at risk for valvular disease in primary care will be referred to be diagnosed by echocardiography.

As AI continues to integrate into medical diagnostics, how might this technology reshape the patient experience and improve preventative care in the years to come?